Clinical Trial Update: Long-term Safety and Efficacy Evaluation of Lunsekimig (SAR443765) in Adult Participants With Asthma. [Phase 2]

View source ↗

Summary

This entry notes an ongoing Phase 2 clinical trial evaluating the long-term safety and efficacy of Lunsekimig (SAR443765) in adults with asthma, sponsored by Sa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Lunsekimig (Lunsekimig)

Snippet

Sponsor: Sanofi | Conditions: Asthma | Phase 2 | Status: RECRUITING